Product Description

🔹 Product Overview
Pamorelin LA 22.5 mg Injection is a long-acting GnRH agonist (Gonadotropin-Releasing Hormone agonist) used in hormone-dependent medical conditions.
Contains Triptorelin 22.5 mg, which helps reduce the production of sex hormones such as testosterone and estrogen.
Commonly prescribed for advanced prostate cancer, endometriosis, and central precocious puberty (early puberty).

🔹 Key Uses
Treatment of advanced and metastatic prostate cancer
Management of endometriosis
Treatment of central precocious puberty (CPP)
Hormonal suppression therapy in selected endocrine conditions under specialist supervision.

🔹 Composition
Active Ingredient: Triptorelin 22.5 mg
Therapeutic Class: Hormone Therapy / Antineoplastic Agent
Drug Category: GnRH Agonist

🔹 How It Works
Initially stimulates hormone production, followed by long-term suppression of testosterone in men and estrogen in women.
Helps slow the growth of hormone-sensitive cancer cells.
Reduces hormone-related symptoms associated with endometriosis and early puberty.

🔹 Key Benefits
Effective prostate cancer hormone therapy
Helps control progression of hormone-sensitive tumors
Reduces symptoms of endometriosis
Helps delay premature puberty in children
Long-acting depot formulation requiring less frequent dosing.

🔹 Dosage and Administration
Administered only by a qualified healthcare professional.
Given as an intramuscular or subcutaneous injection as directed by the physician.
Treatment schedule depends on the medical condition and specialist recommendation.
Regular monitoring of hormone levels may be required.

🔹 Possible Side Effects
Hot flashes
Increased sweating
Weakness or fatigue
Back pain
Headache
Erectile dysfunction (in male patients)
Injection site reactions.

🔹 Precautions
Use only under specialist medical supervision.
Inform your doctor about osteoporosis, heart disease, diabetes, liver disease, or kidney disorders.
Not recommended during pregnancy or breastfeeding.
Long-term therapy may reduce bone mineral density; monitoring may be advised.
Inform your healthcare provider about all current medications.